Cleared Traditional

K211176 - Smith & Nephew Hip Systems

K211176 is the FDA 510(k) clearance for Smith & Nephew Hip Systems by Smith & Nephew, Inc.. It is a Class 2 Orthopedic device (product code LPH) cleared through the Traditional 510(k) pathway after a 437-day FDA review.

K211176 · Smith & Nephew, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
437d
Days
Class 2
Risk

K211176 is an FDA 510(k) clearance for the Smith & Nephew Hip Systems. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Smith & Nephew, Inc. (Memphis, US). The FDA issued a Cleared decision on July 1, 2022 after a review of 437 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Orthopedic submissions.

View all Smith & Nephew, Inc. devices

Submission Details

510(k) Number K211176 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 20, 2021
Decision Date July 01, 2022
Days to Decision 437 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
315d slower than avg
Panel avg: 122d · This submission: 437d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 439
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K211176.
EMPHASYS Acetabular System
K221636 · Depuy Ireland UC · Sep 2022
OR3O Dual Mobility System
K220959 · Smith & Nephew, Inc. · Aug 2022
My3D® Personalized Pelvic Reconstruction
K212815 · Onkos Surgical · Jul 2022
DePuy 3D Additive TriFlange Acetabular Cup
K201348 · Depuy International, Ltd. · Jun 2022
BENCOX Mirabo Z Cup Cortinium
K210614 · Corentec Co., Ltd. · May 2022
BENCOX Mirabo Cup System
K220468 · Corentec Co., Ltd. · May 2022